- Dosage: Paclitaxel 100 mg
- Volume: 20 ml Vial
- Packaging: 20 ml Vial* 1/box*800 carton
- Shelf Life: 36 months
Package:
Product Description
Product Overview
Paclitaxel for Injection (Albumin Bound) 100mg is a sterile, lyophilized formulation of paclitaxel in which the active drug is bound to albumin nanoparticles using nab-technology (nanoparticle albumin-bound technology). Each vial contains 100mg of paclitaxel as a white to yellow, sterile lyophilized powder. After reconstitution with 20mL of 0.9% Sodium Chloride Injection, the resulting suspension has a concentration of 5mg/mL and appears as a uniform, milky-white suspension of albumin-bound paclitaxel nanoparticles with an average particle size of approximately 130 nanometers.
Paclitaxel Albumin-Bound 100mg/20mL: What the Published Guidance Says
Cytotoxic and targeted agents spanning the taxane, antifolate and EGFR-tyrosine-kinase-inhibitor classes, supplied with the analytical and stability documentation oncology procurement requires.
Paclitaxel Albumin-Bound 100mg/20mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Oncology range overview.
- Paclitaxel: premedication is part of the product's use The same review records that paclitaxel is associated with a high incidence of neutropenia, frequently severe, and can cause hypersensitivity reactions in up to 30% of patients, so premedication is required to reduce that risk. Alopecia is described as universal and peripheral neuropathy common, both reversible. WHO EML Expert Committee — Non-small cell lung cancer review
- WHO applies a hard benefit threshold to cancer listings When the September 2025 revision was prepared, WHO evaluated 25 cancer medicines across seven applications and states that only therapies proven to prolong life by at least four to six months are included on the Model List. Listing is therefore a deliberately narrow signal, not a catalogue of everything approved. WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
- 2025 extended access to checkpoint inhibitors Pembrolizumab was added to the Model List as first-line monotherapy for metastatic cervical cancer, metastatic colorectal cancer and metastatic non-small cell lung cancer, with atezolizumab and cemiplimab as therapeutic alternatives for the lung indication. WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Paclitaxel Albumin-Bound 100mg/20mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.
Supply & Specification Data for Paclitaxel Albumin-Bound 100mg/20mL
| Product Name | Paclitaxel for Injection (Albumin Bound) |
| Specification | 100mg per vial; reconstitute to 20mL (5mg/mL suspension) |
| Dosage Form | Sterile Lyophilized Powder for Suspension for Intravenous Infusion |
| Active Ingredient | Paclitaxel (bound to albumin nanoparticles) |
| Pharmacological Class | Taxane-Class Antineoplastic Agent |
| Route of Administration | Intravenous infusion only (after reconstitution and dilution) |
| Storage | Store at 20°C to 25°C (excursions permitted between 15°C and 30°C). Do not refrigerate or freeze. Protect from light. Keep vial in outer carton until use. |
| Therapeutic group | Oncology — Oncology |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Pemetrexed Disodium Injection 100mg, Sunitinib Malate 12.5mg Capsules, Afatinib Dimaleate 40mg Tablets, Erlotinib Hydrochloride 150mg Tablets, Gefitinib Tablets 250mg.
Testing, Monographs & Batch Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Every batch of Paclitaxel Albumin-Bound 100mg/20mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The batch record for this product normally includes:
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Pack Configuration, Artwork & Shipping Documents
- Pack size: 100mg lyophilized powder in glass vial with rubber stopper and aluminum flip-off cap. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store at 20°C to 25°C (excursions permitted between 15°C and 30°C). Do not refrigerate or freeze. Protect from light. Keep vial in outer carton until use..
- Shelf life: 36 months (unopened, dry powder). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Dossier, Authority Filings & Tender Documentation
Documents for Paclitaxel Albumin-Bound 100mg/20mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
The context for Paclitaxel Albumin-Bound 100mg/20mL is its place among cancer medicines reviewed for the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.
Buyer Questions about Paclitaxel Albumin-Bound 100mg/20mL
What pack size is available for Paclitaxel Albumin-Bound 100mg/20mL?
This presentation is normally supplied as 100mg lyophilized powder in glass vial with rubber stopper and aluminum flip-off cap. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.
What documentation comes with a shipment of Paclitaxel Albumin-Bound 100mg/20mL?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Paclitaxel Albumin-Bound 100mg/20mL support a registration filing?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Do you supply albumin-bound paclitaxel?
Yes — albumin-bound paclitaxel 100 mg/20 mL, supplied with assay, impurity and sterility documentation on the batch COA.
What documentation comes with an oncology order?
Batch COA including the full impurity profile and sterility results, stability data, DMF and dossier packages, plus registration support documents.
Other Oncology Products in This Range
- Pemetrexed Disodium Injection 100mg — 100mg
- Sunitinib Malate 12.5mg Capsules — 12.5mg
- Afatinib Dimaleate 40mg Tablets — 40mg
- Erlotinib Hydrochloride 150mg Tablets — 150mg
- Gefitinib Tablets 250mg — 250mg
Browse the full Oncology range; all Injectables; the complete product catalogue.
Request a Quotation for Paclitaxel Albumin-Bound 100mg/20mL
For tenders and programme supply, send the line item, pack size, quantity and destination for Paclitaxel Albumin-Bound 100mg/20mL 100mg. We return a quotation with lead time, documentation list and sample availability in one response.
Sources & Regulatory Notes
- WHO EML Expert Committee — Non-small cell lung cancer review
- WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
